# Autologous Stromal Vascular Fraction of Cells for Treatment of Knee Articular Cartilage Dystrophy

> **NCT02827851** · PHASE2 · UNKNOWN · sponsor: **Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation** · enrollment: 200 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **PROCEDURE:** Liposuction
- **OTHER:** SVF isolation
- **OTHER:** Intraarticular administration of autologous SVF

## Key facts

- **NCT ID:** NCT02827851
- **Lead sponsor:** Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2018-05
- **Final completion:** 2018-11
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2017-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02827851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02827851, "Autologous Stromal Vascular Fraction of Cells for Treatment of Knee Articular Cartilage Dystrophy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02827851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*